Dx Pcr Pro
Dec 27 (Reuters) - Co-Diagnostics Inc CODX.O :
* CO-DIAGNOSTICS, INC. COMPLETES SUBMISSION TO FDA FOR CO-DX
PCR
PRO
* CO-DIAGNOSTICS INC - SUBMITTED CO-DX PCR COVID-19 TEST
WITH
CO-DX PCR PRO INSTRUMENT FOR REVIEW BY FDA FOR EMERGENCY USE
AUTHORIZATION
Source text for Eikon: ID:nPnb458kca
Further company coverage: CODX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Co-Diagnostics
See all newsDiagnostics' Joint Venture Cosara Diagnostics Announces Publication Of Peer-Reviewed Hpv Screening Study Using Cosara's Saragene® Test
Diagnostics - Cosara To Initiate Sales Activities Across India And South Asia
Diagnostics’ Brian Brown Stepped Down As CFO Effective September 2
Diagnostics Q2 revenue rises slightly amid international expansion
Diagnostics - Amends Equity Distribution Agreement With Maxim Group For Common Stock Sale - SEC Filing